Polar Asset Management Partners’s Avadel Pharmaceuticals AVDL Stock Holding History

Polar Asset Management Partners’s Portfolio AVDL Stock Details AVDL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-105,399	Closed	-$2.27M	–	700
2025 Q4	$2.27M	Buy	+105,399	New	+$2.05M	0.03%	364
2024 Q2	–	Sell	-69,700	Closed	-$1.18M	–	713
2024 Q1	$1.18M	Buy	69,700 +10,200	+17%	+$152K	0.02%	418
2023 Q4	$840K	Buy	+59,500	New	+$699K	0.01%	442

Other funds holding AVDL

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Polar Asset Management Partners's AVDL Position: Q1 2026 in Review

Polar Asset Management Partners sold out of Avadel Pharmaceuticals (AVDL) in Q1 2026, closing a stake of 105,399 shares — an estimated $2.27M sold.

Polar Asset Management Partners first reported a position in AVDL in Q4 2023 and held it in 3 quarters. The position peaked at $2.27M in Q4 2025. 2 funds tracked by Wall St. Rank hold AVDL as of Q1 2026.

Polar Asset Management Partners reported no remaining Avadel Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
Polar Asset Management Partners sold 105,399 Avadel Pharmaceuticals shares in Q1 2026, an estimated $2.27M.
Polar Asset Management Partners first reported a position in Avadel Pharmaceuticals in Q4 2023 and held it in 3 quarters.
Polar Asset Management Partners's Avadel Pharmaceuticals position peaked at $2.27M in Q4 2025.
2 funds tracked by Wall St. Rank held Avadel Pharmaceuticals as of Q1 2026.

Based on Polar Asset Management Partners's 13F filing for Q1 2026, filed 15 May 2026.